Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke

Background and Purpose: Dual antiplatelet therapy (DAPT), compared to single antiplatelet therapy (SAPT), lowers the risk of stroke or death early after TIA and minor ischemic stroke. Prior trials excluded moderate to severe strokes, due to a potential increased risk of bleeding. We aimed to compare...

Full description

Bibliographic Details
Main Authors: Ossama Khazaal, Aaron Rothstein, Muhammad R. Husain, Matthew Broderick, Daniel Cristancho, Sahily Reyes-Esteves, Farhan Khan, Christopher G. Favilla, Steven R. Messé, Michael T. Mullen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Neurology
Subjects:
dual antiplatelet therapy
moderate stroke
severe stroke
secondary prevention
bleeding risk
bleeding rate
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.728111/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.728111/full

Similar Items